FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

The FDA approved a supplemental application for CLOBEX (clobetasol propionate) submitted by Galderma Laboratories to update its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Dermatitis
• Lichen Planus
• Psoriasis

Drugs mentioned

• CLOBEX (clobetasol propionate)

Snippet

SUPPL AP for CLOBEX (CLOBETASOL PROPIONATE)